EUVIMEDEUVIMED entdecken
Crossref

HLA Gene Editing of the Type I Diabetes Susceptible DQ8 Allele Inhibits Hybrid Insulin Peptide Binding and T Cell Activation 2310163

Niyun Jin, Maki Nakayama, Jena Baertschi, Brian Freed, Christina Roark

The Journal of Immunology · 01.08.2026 · 215 (Supplement_1)

DOI: 10.1093/jimmun/vkag141.1703 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 28.07.2026. Verfasst von Niyun Jin und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The risk for developing T1D is strongly associated with HLA-DQ8 in humans and I-Ag7 in NOD mice, both of which have an alanine at position 57 and an asparagine in position 82. In the NOD mouse model, replacing alanine (A) with aspartic acid (D) renders the mice resistant to diabetes, suggesting that the edit should block binding of autoantigens. Here, we compared the T1D-specific gene edit (A57D) with a universal approach replacing the invariant asparagine (N) with leucine (L) at position 82 (N82L). Asparagine forms hydrogen bonds with the peptide backbone near the N-terminus of a peptide and appears to be critical for all high-affinity peptide binding.

Methods

DQ8, DQ8(A57D) and DQ8(N82L) edits were cloned individually into the K562 cell line. HIP-11, a T1D pathogenic peptide, was synthesized with a biotinylated polyethylene-3 linker on the N-terminus. K562 transfectants were cultured with biotinylated peptide overnight. Peptide binding was detected with streptavidin-PE and analyzed by flow cytometry. The T cell transductant (GSE.8E3), which was generated by cloning the HIP-11-specific T cell receptor from a T1D patient, was co-cultured with HLA-transfected K562 cells plus HIP-11 and T cell activation measured using an NFAT reporter.

Results

Replacing alanine at position 57 with aspartic acid in DQ8 reduced HIP-11 peptide binding by 37%. In contrast, replacing asparagine at position 82 with leucine reduced HIP-11 peptide binding by 87%. However, both edits completely blocked T cell activation of HIP-11-specific T cells.

Conclusion

The global (N82L) gene edit in DQ8 reduced binding of HIP-11 more effectively than the A57D edit. However, both gene edits blocked the activation of a HIP-11 pathogenic T1D T cell line. These findings support the potential development of HLA gene editing to treat T1D. Funding Source n/a Topic Categories Therapeutic Approaches to Autoimmunity (THER)

Zitieren

APA

Jin, N., Nakayama, M., Baertschi, J., Freed, B., & Roark, C. (2026). HLA Gene Editing of the Type I Diabetes Susceptible DQ8 Allele Inhibits Hybrid Insulin Peptide Binding and T Cell Activation 2310163. The Journal of Immunology, 215(Supplement_1). https://doi.org/10.1093/jimmun/vkag141.1703

Vancouver

Jin N, Nakayama M, Baertschi J, Freed B, Roark C. HLA Gene Editing of the Type I Diabetes Susceptible DQ8 Allele Inhibits Hybrid Insulin Peptide Binding and T Cell Activation 2310163. The Journal of Immunology. 2026;215(Supplement_1). doi:10.1093/jimmun/vkag141.1703

BibTeX
@article{Jin2026,
  author = {Jin, Niyun and Nakayama, Maki and Baertschi, Jena and Freed, Brian and Roark, Christina},
  title = {HLA Gene Editing of the Type I Diabetes Susceptible DQ8 Allele Inhibits Hybrid Insulin Peptide Binding and T Cell Activation 2310163},
  journal = {The Journal of Immunology},
  year = {2026},
  volume = {215},
  number = {Supplement_1},
  doi = {10.1093/jimmun/vkag141.1703}
}
Kostenlos starten →